Home › Alzheimer's Disease › Colorado
Alzheimer's Disease clinical trials in Colorado
13 studies for Alzheimer's Disease are looking for participants at sites in Colorado.
Cities in Colorado
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- CenExel Rocky Mountain Clinical Research, Englewood
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Denver, CO, Englewood
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Sep 21, 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Alpine Clinical Research Center - Boulder - 47th Street /ID# 277856, Boulder
RecruitingPhase 1/2
Ages 50 to 90 · All sexes · Updated Sep 18, 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Research of the Rockies, Colorado Springs
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Sep 17, 2026 · NCT06976203Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Denver
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Aug 27, 2026 · NCT06887192A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Mountain Neurological Research Center, Basalt
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Colorado Anschutz, Aurora
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895CBD for Individuals at Risk for Alzheimer's Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Jun 15, 2026 · NCT05822362Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 2
Ages 60 to 85 · All sexes · Updated Apr 30, 2026 · NCT04902703Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
- University of Colorado, Aurora
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 24, 2024 · NCT05877391Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Vivage/Beecan Corporation, Lakewood
Recruiting
Ages 50 and older · All sexes · Updated Mar 12, 2024 · NCT05820919From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.